May 17 (Reuters) - Royalty Pharma PLC (RPRX.O) :
<ul>
<li>ROYALTY PHARMA - NEW CAPITAL DEPLOYMENT TARGET OF $10-12 BILLION OVER THE NEXT FIVE YEARS</li>
<li>ROYALTY PHARMA - OUTLOOK FOR 2020-2025 ADJUSTED CASH RECEIPTS (NON-GAAP) CAGR RAISED TO 11-14%</li>
<li>ROYALTY PHARMA - SEES ACADEMIC INSTITUTIONS,NON-PROFITS WILL SPEND MORE THAN $1 TRILLION TO FUND LIFE SCIENCES RESEARCH, DEVELOPMENT OVER NEXT DECADE</li>
<li>ROYALTY PHARMA - INTRODUCED ITS TARGET FOR ADJUSTED CASH RECEIPTS TO GROW 10% OR MORE ON A COMPOUNDED ANNUAL BASIS FROM 2020 TO 2030 Further company coverage: (RPRX.O)</li>
</ul>

RPRX

May 17 (Reuters) - Royalty Pharma PLC:

Royalty Pharma - New Capital Deployment Target Of $10-12 Billion Over The Next Five Years